Literature DB >> 15659928

Bacteriology of urinary tract infection associated with indwelling J ureteral stents.

Elijah O Kehinde1, Vincent O Rotimi, Adel Al-Hunayan, Hamdy Abdul-Halim, Fareeda Boland, Khaleel A Al-Awadi.   

Abstract

PURPOSE: To investigate the microorganisms responsible for urinary tract infection (UTI) and stent colonization in patients with indwelling J ureteral stents and to compare the antimicrobial susceptibility pattern of the isolates from urine and J stents in order to establish the etiologic agents of bacteriuria and colonized stents in such patients and provide baseline data on an antibiotic policy for the urology unit. PATIENTS AND METHODS: Midstream urine from 250 patients requiring J stent insertion was investigated microbiologically prior to stent insertion and on the day of stent removal. After stent removal, 3 to 5 cm of the tip located in the bladder was also sent for culture. Patients' bio-data and underlying diseases were documented. Those with no known systemic diseases ("normal patients") were also studied as controls. Of the 250 patients studied, 152 (61%) were normal, while 27 (11%), 53 (21%), and 18 (7%) had diabetes mellitus (DM), chronic renal failure (CRF), and diabetic nephropathy (DN), respectively. The mean duration of stent retention was 27 days. All microbial isolates were tested for their susceptibility to a panel of 10 antibiotics.
RESULTS: Twelve patients (5%) before stent insertion and 42 patients (17%; P < 0.001) on the day of stent removal had positive urine cultures. One hundred four stents (42%) were culture positive. Of the 104 patients with positive stent cultures, in 62 patients (60%), urine culture was sterile. The commonest isolates were Escherichia coli, Enterococcus spp., Staphylococcus spp., Pseudomonas, and Candida spp. On the day of stent removal, urine culture was positive in 28% of the normal patients compared with 57% (P = 0.11), 78% (P < 0.001), and 62% (P < 0.001) of patients with CRF, DM, and DN, respectively. Stent isolates were more resistant to antibiotics than the organism isolated before stent insertion.
CONCLUSION: An indwelling J ureteral stent carries a significant risk of bacteriuria and stent colonization. The sensitivity of urine culture to stent colonization is low, and therefore, a negative culture does not rule out a colonized stent. Bacteria cultured from urine after stent insertion and from the stents are more resistant to antibiotics than are those cultured from urine before stent insertion. Norfloxacin or ciprofloxacin is recommended as prophylaxis prior to stent insertion, and an aminoglycoside can be added to treat symptomatic patients with severe infections.

Entities:  

Mesh:

Year:  2004        PMID: 15659928     DOI: 10.1089/end.2004.18.891

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  27 in total

1.  Iatrogenic ureteral injury in colorectal cancer surgery: a nationwide study comparing laparoscopic and open approaches.

Authors:  Peter Andersen; Lars Maagaard Andersen; Lene H Iversen
Journal:  Surg Endosc       Date:  2014-08-26       Impact factor: 4.584

2.  [Plasma-deposited carbon coating on urological indwelling catheters: Preventing formation of encrustations and consecutive complications].

Authors:  N Laube; J Bradenahl; A Meissner; J V Rappard; L Kleinen; S C Müller
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 3.  Ureteral stent-associated complications--where we are and where we are going.

Authors:  Dirk Lange; Samir Bidnur; Nathan Hoag; Ben H Chew
Journal:  Nat Rev Urol       Date:  2014-12-23       Impact factor: 14.432

4.  Comparison of the roll-plate and sonication techniques in the diagnosis of microbial ureteral stent colonisation: results of the first prospective randomised study.

Authors:  G Bonkat; O Braissant; M Rieken; G Müller; R Frei; Andre van der Merwe; F P Siegel; T C Gasser; S Wyler; A Bachmann; A F Widmer
Journal:  World J Urol       Date:  2012-10-05       Impact factor: 4.226

5.  Predictive risk factors for systemic inflammatory response syndrome following ureteroscopic laser lithotripsy.

Authors:  Yusuke Uchida; Ryoji Takazawa; Sachi Kitayama; Toshihiko Tsujii
Journal:  Urolithiasis       Date:  2017-07-10       Impact factor: 3.436

6.  How long should double J stent be kept in after ureteroscopic lithotripsy?

Authors:  Katsumi Shigemura; Tomihiko Yasufuku; Kunito Yamanaka; Masuo Yamahsita; Soichi Arakawa; Masato Fujisawa
Journal:  Urol Res       Date:  2011-09-17

7.  Improved detection of microbial ureteral stent colonisation by sonication.

Authors:  Gernot Bonkat; Malte Rieken; Cyrill A Rentsch; Stephen Wyler; Antje Feike; Juliane Schäfer; Thomas Gasser; Andrej Trampuz; Alexander Bachmann; Andreas F Widmer
Journal:  World J Urol       Date:  2010-03-21       Impact factor: 4.226

8.  RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.

Authors:  Oscar Cirioni; Roberto Ghiselli; Daniele Minardi; Fiorenza Orlando; Federico Mocchegiani; Carmela Silvestri; Giovanni Muzzonigro; Vittorio Saba; Giorgio Scalise; Naomi Balaban; Andrea Giacometti
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  Anti-adhesive coating and clearance of device associated uropathogenic Escherichia coli cystitis.

Authors:  Andrea Pechey; Chelsea N Elwood; Geoffrey R Wignall; Jeffrey L Dalsin; Bruce P Lee; Maaike Vanjecek; Ian Welch; Raymond Ko; Hassan Razvi; Peter A Cadieux
Journal:  J Urol       Date:  2009-08-15       Impact factor: 7.450

10.  Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities.

Authors:  Allison R Eberly; Connor J Beebout; Ching Man Carmen Tong; Gerald T Van Horn; Hamilton D Green; Madison J Fitzgerald; Shuvro De; Emily K Apple; Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean; Douglass B Clayton; Charles W Stratton; Jonathan E Schmitz; Maria Hadjifrangiskou
Journal:  J Mol Biol       Date:  2019-11-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.